Food & Drug Retailing
18 companies across the library’s three pools, one row each. The columns are the line items this kind of business is read on; each header names its basis, and the margins and returns are medians over each company’s readable record — the through-cycle level, never one year’s print. Rows open largest first by latest-year revenue, and every column sorts both ways — the re-ordering is the reader’s own act, and a sorted view keeps its order in the address bar. The company stays in view as the columns scroll. A dash is a figure that could not be read; n/a is one that does not apply to that member; both sit at the back of a sorted column.
From the latest filings · data as of July 9, 2026.
As a group: median revenue $8.8B; median gross margin 25.9%; median operating margin 2.7%; median owner earnings $372M; median return on invested capital 9.6%; 5 of 17 hold net cash. Medians of this table’s own columns, over the members each applies to · data as of July 9, 2026.
| latest fiscal year, USD | median over the record | median over the record | op. cash − maintenance capex · latest FY, USD | after tax · median over the record | debt − cash & ST investments · latest FY, USD | ||||
|---|---|---|---|---|---|---|---|---|---|
| CVS | CVS Health Corporation | Food & Drug Retailing | $402.1B | 38.9% | 3.8% | $7.8B | 6.8% | $62.0B | |
| KR | Kroger Company (The) | Food & Drug Retailing | $147.6B | — | 2.1% | $3.5B | 11.8% | $12.5B | |
| ACI | Albertsons | Food & Drug Retailing | $83.2B | 27.9% | 1.9% | $527M | 12.0% | $9.6B | |
| SYY | Sysco Corporation | Food & Drug Retailing | $81.4B | 18.5% | 3.8% | $1.6B | 16.5% | $12.2B | |
| 8267 | Aeon | Food & Drug Retailing | $57.6B | 27.6% | 2.7% | — | 4.5% | $11.7B | |
| 3382 | Seven & i Holdings | Food & Drug Retailing | $54.8B | 18.0% | 5.4% | $2.1B | 6.9% | $20.7B | |
| USFD | US Foods | Food & Drug Retailing | $39.4B | 17.4% | 2.7% | $959M | 8.2% | $5.2B | |
| CASY | Casey's General | Food & Drug Retailing | $17.6B | — | 4.2% | $928M | 10.7% | $1.9B | |
| SFM | Sprouts Farmers | Food & Drug Retailing | $8.8B | 36.2% | 5.1% | $558M | 27.2% | +$125M cash | |
| ARKO | ARKO Corp. | Food & Drug Retailing | $7.6B | — | 1.3% | $65M | 9.6% | $601M | |
| IMKTA | Ingles Markets Incorporated | Food & Drug Retailing | $5.3B | 24.1% | 3.6% | $40M | 8.6% | $144M | |
| WMK | Weis Markets Inc. | Food & Drug Retailing | $5.0B | — | 2.6% | $82M | 7.4% | +$214M cash | |
| GO | Grocery Outlet | Food & Drug Retailing | $4.7B | 30.4% | 2.7% | $216M | 5.3% | $423M | |
| VLGEA | Village Super Market Inc. | Food & Drug Retailing | $2.3B | 28.1% | 2.1% | $57M | 9.9% | $285M | |
| YI | 111 Inc. | Food & Drug Retailing | $1.9B | 5.7% | -5.8% | $17M | — | +$75M cash | |
| GRDN | Guardian Pharmacy Services Inc. | Food & Drug Retailing | $1.4B | — | — | $87M | — | +$66M cash | |
| NGVC | Natural Grocers by Vitamin Cottage Inc. | Food & Drug Retailing | $1.3B | — | 2.7% | $24M | 14.5% | +$18M cash | |
| TBBB | BBB Foods Inc. Class A | Food & Drug Retailing | as filed: MX$78.2B | 16.0% | 1.7% | as filed: MX$3.1B | — | — |
Every figure is recomputed from the company’s own SEC or EDINET filings, the same way as on its page; the columns name facts, weigh nothing, and form no rank. Foreign filers are stated in US dollars at the dated reference rate (as of 2026-07-17) so each money column sorts on one basis; their own pages keep the records as filed. A foreign filer whose conversion terms are missing shows its money as filed and sorts to the back of the column — never a guessed conversion. Ratios and margins are currency-free.